Validation of Systemic Complement Signatures in the Progression of Chronic Obstructive Pulmonary Disease.
作者信息
DiLillo Katarina M, Ruvuna Lisa, Pratte Katherine A, Serban Karina A, Labaki Wassim W, Han MeiLan K, Freeman Christine M, Bowler Russell P, Curtis Jeffrey L, Arnold Kelly B
机构信息
Department of Biomedical Engineering.
Division of Pulmonary and Critical Care and.
出版信息
Am J Respir Crit Care Med. 2024 Nov 15;210(10):1269-1272. doi: 10.1164/rccm.202311-2059LE.
Abstract
摘要
相似文献
1
Validation of Systemic Complement Signatures in the Progression of Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病进展中全身补体特征的验证
Am J Respir Crit Care Med. 2024 Nov 15;210(10):1269-1272. doi: 10.1164/rccm.202311-2059LE.
2
Sputum colour charts to guide antibiotic self-treatment of acute exacerbation of chronic obstructive pulmonary disease: the Colour-COPD RCT.用于指导慢性阻塞性肺疾病急性加重期抗生素自我治疗的痰液颜色图表：Colour-COPD随机对照试验
Health Technol Assess. 2025 May;29(28):1-42. doi: 10.3310/KPFD5558.
3
Vitamin D for the management of chronic obstructive pulmonary disease.维生素D用于慢性阻塞性肺疾病的管理
Cochrane Database Syst Rev. 2024 Sep 27;9(9):CD013284. doi: 10.1002/14651858.CD013284.pub2.
4
Glycopyrrolate/formoterol fumarate MDI in mild-to-moderate chronic obstructive pulmonary disease (PIONEER): a protocol for a randomised, double-blind, placebo-controlled trial.格隆溴铵/富马酸福莫特罗定量吸入气雾剂用于轻至中度慢性阻塞性肺疾病（先锋研究）：一项随机、双盲、安慰剂对照试验方案
BMJ Open Respir Res. 2025 Jun 15;12(1):e002656. doi: 10.1136/bmjresp-2024-002656.
5
Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重期皮质类固醇治疗的不同疗程
Cochrane Database Syst Rev. 2018 Mar 19;3(3):CD006897. doi: 10.1002/14651858.CD006897.pub4.
6
Effects of whole body vibration on pulmonary function, functional exercise capacity and quality of life in people with chronic obstructive pulmonary disease: a systematic review.全身振动对慢性阻塞性肺疾病患者肺功能、功能锻炼能力及生活质量的影响：一项系统评价
Clin Rehabil. 2016 May;30(5):419-31. doi: 10.1177/0269215515589202. Epub 2015 Jun 2.
7
Anemia in chronic obstructive pulmonary disease: A systematic review.慢性阻塞性肺疾病中的贫血：系统综述。
Respir Investig. 2022 Jul;60(4):510-521. doi: 10.1016/j.resinv.2022.03.006. Epub 2022 Apr 26.
8
Diagnostic MicroRNA Signatures to Support Classification of Pulmonary Hypertension.支持肺动脉高压分类的诊断性微小RNA特征
Circ Genom Precis Med. 2025 Jun;18(3):e004862. doi: 10.1161/CIRCGEN.124.004862. Epub 2025 Apr 18.
9
Prevalence and Clinical Correlates of Radiologically Detected Coronary Artery Disease in Chronic Obstructive Pulmonary Disease: A Cross-Sectional Observational Study.慢性阻塞性肺疾病中经放射学检测的冠状动脉疾病的患病率及其临床关联：一项横断面观察性研究。
Am J Respir Crit Care Med. 2025 Jun;211(6):946-956. doi: 10.1164/rccm.202404-0838OC.
10
Long-acting beta(2)-agonist in addition to tiotropium versus either tiotropium or long-acting beta(2)-agonist alone for chronic obstructive pulmonary disease.长效β₂受体激动剂联合噻托溴铵与单独使用噻托溴铵或长效β₂受体激动剂治疗慢性阻塞性肺疾病的比较
Cochrane Database Syst Rev. 2012 Apr 18;4(4):CD008989. doi: 10.1002/14651858.CD008989.pub2.
本文引用的文献
1
A blood and bronchoalveolar lavage protein signature of rapid FEV decline in smoking-associated COPD.吸烟相关 COPD 患者快速 FEV 下降的血液和支气管肺泡灌洗蛋白特征。
Sci Rep. 2023 May 22;13(1):8228. doi: 10.1038/s41598-023-32216-0.
2
Comparison of Proteomic Assessment Methods in Multiple Cohort Studies.多队列研究中蛋白质组学评估方法的比较。
Proteomics. 2020 Jun;20(12):e1900278. doi: 10.1002/pmic.201900278.
3
Identifying Protein-metabolite Networks Associated with COPD Phenotypes.识别与慢性阻塞性肺疾病（COPD）表型相关的蛋白质-代谢物网络。
Metabolites. 2020 Mar 25;10(4):124. doi: 10.3390/metabo10040124.
4
Cigarette smoke-induced reduction of C1q promotes emphysema.香烟烟雾引起的 C1q 减少促进肺气肿。
JCI Insight. 2019 May 21;5(13):124317. doi: 10.1172/jci.insight.124317.
5
Lectin Complement Pathway in Emphysema.肺气肿中的凝集素补体途径。
Am J Respir Crit Care Med. 2019 Mar 1;199(5):659-661. doi: 10.1164/rccm.201807-1380LE.
6
Biomarkers Predictive of Exacerbations in the SPIROMICS and COPDGene Cohorts.SPIROMICS和COPDGene队列中预测病情加重的生物标志物
Am J Respir Crit Care Med. 2017 Feb 15;195(4):473-481. doi: 10.1164/rccm.201607-1330OC.
7
Common Genetic Polymorphisms Influence Blood Biomarker Measurements in COPD.常见基因多态性影响慢性阻塞性肺疾病患者血液生物标志物的检测结果
PLoS Genet. 2016 Aug 17;12(8):e1006011. doi: 10.1371/journal.pgen.1006011. eCollection 2016 Aug.
8
Activation of C3a receptor is required in cigarette smoke-mediated emphysema.香烟烟雾介导的肺气肿需要C3a受体的激活。
Mucosal Immunol. 2015 Jul;8(4):874-85. doi: 10.1038/mi.2014.118. Epub 2014 Dec 3.
9
Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS).COPD 研究中的亚人群和中间结局设计（SPIROMICS）。
Thorax. 2014 May;69(5):491-4. doi: 10.1136/thoraxjnl-2013-203897. Epub 2013 Sep 12.
10
Changes in forced expiratory volume in 1 second over time in COPD.COPD 患者 1 秒用力呼气容积随时间的变化。
N Engl J Med. 2011 Sep 29;365(13):1184-92. doi: 10.1056/NEJMoa1105482. Epub 2011 Sep 26.
Zotero 插件